Comparing Survival Outcomes and Impact of EPIC in Patients Undergoing CRS/HIPEC for Mucinous Appendiceal Neoplasm
Anticancer Research · 2023
DOI: 10.21873/anticanres.16223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Melanie Mercado und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobilliary and Surgical Oncology Unit, Department of Surgery, St George Hospital, Kogarah, NSW, Australia. Hauptthemen laut MEDLINE: Appendiceal Neoplasms, Adenocarcinoma, Mucinous, Peritoneal Neoplasms, Hyperthermia, Induced. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hepatobilliary and Surgical Oncology Unit, Department of Surgery, St George Hospital, Kogarah, NSW, Australia.
- St George and Sutherland Clinical School, University of New South Wales, Sydney, NSW, Australia.
- School of Medicine, University of Notre Dame, Sydney, NSW, Australia.
- Hepatobilliary and Surgical Oncology Unit, Department of Surgery, St George Hospital, Kogarah, NSW, Australia; david.morris@unsw.edu.au.
Zitieren
APA
Mercado, M., Shamavonian, R., Cheng, E., Ahmadi, N., & Morris, D. L. (2023). Comparing Survival Outcomes and Impact of EPIC in Patients Undergoing CRS/HIPEC for Mucinous Appendiceal Neoplasm. Anticancer Research. https://doi.org/10.21873/anticanres.16223
Vancouver
Mercado M, Shamavonian R, Cheng E, Ahmadi N, Morris DL. Comparing Survival Outcomes and Impact of EPIC in Patients Undergoing CRS/HIPEC for Mucinous Appendiceal Neoplasm. Anticancer Research. 2023. doi:10.21873/anticanres.16223
BibTeX
@article{Mercado2023,
author = {Mercado, Melanie and Shamavonian, Raphael and Cheng, Ernest and Ahmadi, Nima and Morris, David L},
title = {Comparing Survival Outcomes and Impact of EPIC in Patients Undergoing CRS/HIPEC for Mucinous Appendiceal Neoplasm},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16223}
}
EUVIMED